Gadoteric acid Completed Phase 4 Trials for Magnetic Resonance Imaging (MRI) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT03602339Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
NCT02411201DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years